GSK Meningococcal Group B Vaccine
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GSK Meningococcal Group B Vaccine, covering 2025-03-04 to 2026-02-10. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants [Phase 3]